A detailed history of Mackenzie Financial Corp transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 55,992 shares of ZBH stock, worth $6.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
55,992
Previous 49,203 13.8%
Holding current value
$6.17 Million
Previous $5.34 Million 13.16%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$104.47 - $116.17 $709,246 - $788,678
6,789 Added 13.8%
55,992 $6.04 Million
Q2 2024

Aug 14, 2024

SELL
$106.25 - $130.01 $3.39 Million - $4.15 Million
-31,930 Reduced 39.36%
49,203 $5.34 Million
Q1 2024

May 10, 2024

SELL
$119.98 - $132.61 $4.37 Million - $4.83 Million
-36,457 Reduced 31.0%
81,133 $10.7 Million
Q4 2023

Jan 30, 2024

BUY
$102.72 - $121.7 $140,829 - $166,850
1,371 Added 1.18%
117,590 $14.3 Million
Q3 2023

Oct 25, 2023

BUY
$110.76 - $143.18 $203,687 - $263,308
1,839 Added 1.61%
116,219 $13 Million
Q2 2023

Aug 03, 2023

BUY
$126.43 - $145.6 $11.4 Million - $13.1 Million
89,855 Added 366.38%
114,380 $16.7 Million
Q1 2023

Apr 24, 2023

BUY
$121.91 - $130.94 $30,721 - $32,996
252 Added 1.04%
24,525 $3.17 Million
Q4 2022

Feb 14, 2023

BUY
$104.7 - $128.4 $234,109 - $287,102
2,236 Added 10.15%
24,273 $3.09 Million
Q3 2022

Oct 07, 2022

SELL
$101.65 - $119.27 $14.6 Million - $17.1 Million
-143,459 Reduced 86.68%
22,037 $2.3 Million
Q2 2022

Aug 10, 2022

SELL
$102.23 - $133.85 $461,363 - $604,065
-4,513 Reduced 2.65%
165,496 $17.4 Million
Q1 2022

May 13, 2022

BUY
$108.42 - $129.58 $135,850 - $162,363
1,253 Added 0.74%
170,009 $21.7 Million
Q4 2021

Feb 14, 2022

SELL
$115.43 - $146.63 $747,870 - $950,015
-6,479 Reduced 3.7%
168,756 $21.4 Million
Q3 2021

Nov 08, 2021

BUY
$136.35 - $158.76 $1.31 Million - $1.52 Million
9,596 Added 5.79%
175,235 $25.6 Million
Q2 2021

Aug 11, 2021

BUY
$152.95 - $173.41 $1.6 Million - $1.81 Million
10,451 Added 6.73%
165,639 $26.6 Million
Q1 2021

May 14, 2021

SELL
$148.16 - $159.71 $3.29 Million - $3.54 Million
-22,172 Reduced 12.5%
155,188 $24.8 Million
Q4 2020

Feb 10, 2021

SELL
$128.25 - $151.41 $3 Million - $3.54 Million
-23,368 Reduced 11.64%
177,360 $27.3 Million
Q3 2020

Nov 13, 2020

SELL
$113.59 - $141.68 $323,958 - $404,071
-2,852 Reduced 1.4%
200,728 $27.3 Million
Q2 2020

Aug 13, 2020

SELL
$87.02 - $133.4 $2 Million - $3.06 Million
-22,971 Reduced 10.14%
203,580 $23.6 Million
Q1 2020

May 14, 2020

SELL
$78.28 - $155.73 $10.4 Million - $20.8 Million
-133,459 Reduced 37.07%
226,551 $22.2 Million
Q4 2019

Feb 13, 2020

SELL
$127.4 - $146.83 $2.86 Million - $3.3 Million
-22,461 Reduced 5.87%
360,010 $53.9 Million
Q3 2019

Nov 14, 2019

SELL
$113.33 - $138.46 $18.1 Million - $22.1 Million
-159,296 Reduced 29.4%
382,471 $52.5 Million
Q2 2019

Aug 14, 2019

BUY
$108.87 - $125.09 $2.26 Million - $2.6 Million
20,748 Added 3.98%
541,767 $63.8 Million
Q1 2019

May 15, 2019

BUY
$97.5 - $125.79 $20.5 Million - $26.5 Million
210,717 Added 67.91%
521,019 $66.5 Million
Q4 2018

Feb 06, 2019

BUY
$94.4 - $126.76 $6.45 Million - $8.67 Million
68,361 Added 28.26%
310,302 $32.2 Million
Q3 2018

Nov 15, 2018

BUY
$108.41 - $127.64 $1.57 Million - $1.85 Million
14,479 Added 6.37%
241,941 $31.8 Million
Q2 2018

Aug 13, 2018

BUY
$102.12 - $114.04 $4.4 Million - $4.91 Million
43,088 Added 23.37%
227,462 $25.3 Million
Q1 2018

May 14, 2018

BUY
$104.31 - $124.46 $7.67 Million - $9.15 Million
73,544 Added 66.36%
184,374 $20.1 Million
Q4 2017

Feb 13, 2018

BUY
$105.55 - $120.83 $10 Million - $11.5 Million
94,772 Added 590.19%
110,830 $13.4 Million
Q3 2017

Nov 13, 2017

BUY
$106.92 - $117.79 $1.72 Million - $1.89 Million
16,058
16,058 $1.88 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.